Kontigo Care AB (publ)

KONT.ST

Medical - Healthcare Information Services · Healthcare

Exchange

Stockholm Stock Exchange

Winston Score

Winston is worried

Below-average fundamentals — multiple weak pillars.

Data as of Aug 23, 2026 · filings through Mar 31, 2026

How the score breaks down

Quality

Mixed

Growth

Weak

Cash Flow

Weak

Stability

Data not available

Valuation

Data not available

Track this stock — start free trial

Winston Score History

The full picture

Kontigo Care is a Swedish digital health company that helps people recover from alcohol addiction. Its main product is a system called Previct, which combines a breathalyzer device with a mobile app and a care platform that lets healthcare providers monitor patients remotely. The company sells to addiction clinics, hospitals, and public healthcare systems, primarily in Sweden.

The company earns revenue mainly through recurring subscriptions, where healthcare providers pay ongoing fees to use the Previct platform and monitoring service. Kontigo Care operates almost entirely in Sweden, making it a small, early-stage business with a market cap around $100 million. Its moat comes from proprietary technology and the clinical data it has built up, but the negative operating margin shows it is still spending more than it earns. The key growth driver is expanding Previct into more European markets and broader addiction treatment categories, while the main risk is its heavy dependence on a single product in a single country.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+4.3% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+164.1% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

48.8%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~8 years

kr 15M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

kr 15M cash & investments at current burn rate

Growth context

Kontigo Care AB (publ) is growing revenue at 4% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

109.2%

Premium pricing power — 109.2% gross margin

Profit after running costs

Operating Margin

3.3%

Thin — 3.3% operating margin

Return on the money invested

ROCE

-2.6%

Weak — -2.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-0.9%

Shrinking sales (-0.9% YoY)

Profit growth

EPS YoY

-613.4%

Earnings shrinking (-613.4% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-16.8%

Burning cash (-16.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial